Personalized predictions of adverse side effects of the COVID-19 vaccines.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Primary Methods/Results use prospective adverse-effect reports from 19,943 vaccine recipients in Iran and Switzerland across six vaccines; multiple ML models predict eight side effects using demographic/health features, with ROC-AUC evaluation. Retrospective prediction from collected reports; no causal vaccine-risk claim.
Technology: Primary Methods/Results use prospective adverse-effect reports from 19,943 vaccine recipients in Iran and Switzerland across six vaccines; multiple ML models predict eight side effects using demographic/health features, with ROC-AUC evaluation.…
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Primary Methods/Results use prospective adverse-effect reports from 19,943 vaccine recipients in Iran and Switzerland across six vaccines; multiple ML models predict eight side effects using demographic/health features, with ROC-AUC evaluation.…
- Limitation / still unknown
- The result is limited to the reported study population, data and evaluation; broader generalization or real-world benefit was not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9800018/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.